FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)

View source ↗

Summary

The FDA approved a supplemental application for SUCRAID (sacrosidase) submitted by QOL Medical, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Sucrase Deficiency
• Sucrase-isomaltase Deficiency

Drugs mentioned

• SUCRAID (sacrosidase)

Snippet

SUPPL AP for SUCRAID (SACROSIDASE)